| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10052926 | The Journal of Urology | 2005 | 4 Pages |
Abstract
FISH appears to be useful for monitoring patients with superficial bladder cancer for the response to intravesical therapy. Patients with a positive FISH result at the end of treatment are at high risk for progression to muscle invasive bladder cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
BENJAMIN R. KIPP, R. JEFFREY KARNES, SHANNON M. BRANKLEY, AARON R. HARWOOD, V. SHANE PANKRATZ, THOMAS J. SEBO, MICHAEL M. BLUTE, MICHAEL M. LIEBER, HORST ZINCKE, KEVIN C. HALLING,